M A Deeg - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M A Deeg

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Biophysical Journal|January 1, 1989

Adenosine triphosphate utilization rates and metabolic pool sizes in intact cells measured by transfer of 18O from waterS M Dawis, T F Walseth, M A Deeg, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997

Phosphoproteins regulated by the interaction of high-density lipoprotein with human skin fibroblastsW S Garver, M A Deeg, R F Bowen, et al.

American Journal of Physiology. Endocrinology and Metabolism|June 19, 2001

Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetesM A Deeg, R F Bowen, M D Williams, et al.

Diabetes, Obesity & Metabolism|February 7, 2015

Short-term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetesR P Kelly, P Garhyan, E Raddad, et al.

Osteoarthritis and Cartilage|September 22, 2018

CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trialY Jin, C Smith, D Monteith, et al.

Diabetes, Obesity & Metabolism|October 6, 2015

Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitusL L Ilag, M A Deeg, T Costigan, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Biophysical Journal|January 1, 1989

Adenosine triphosphate utilization rates and metabolic pool sizes in intact cells measured by transfer of 18O from waterS M Dawis, T F Walseth, M A Deeg, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997

Phosphoproteins regulated by the interaction of high-density lipoprotein with human skin fibroblastsW S Garver, M A Deeg, R F Bowen, et al.

American Journal of Physiology. Endocrinology and Metabolism|June 19, 2001

Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetesM A Deeg, R F Bowen, M D Williams, et al.

Diabetes, Obesity & Metabolism|February 7, 2015

Short-term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetesR P Kelly, P Garhyan, E Raddad, et al.

Osteoarthritis and Cartilage|September 22, 2018

CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trialY Jin, C Smith, D Monteith, et al.

Diabetes, Obesity & Metabolism|October 6, 2015

Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitusL L Ilag, M A Deeg, T Costigan, et al.

Pageof 3